Following the American Society of Hematology Annual Meeting, Ken Anderson, MD, and David Williams, MD, discussed the latest research and treatments for patients with blood cancers and disorders. View the webchat below. To submit a question to future Dana-Farber live webchats, email email@example.com.
As leaders in blood and cancer research, physicians and scientists from Dana-Farber Cancer Institute and Dana-Farber/Boston Children's Cancer and Blood Disorders Center showcased their advances in this field at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014.
As the premier conference in the field, the ASH Annual Meeting attracts more than 20,000 experts who share their advances in hematologic malignancies — including leukemia, lymphoma, and multiple myeloma — and other blood disorders.
Visitors who stopped by our booth connected with our adult and pediatric physicians and scientists — and learned about our discoveries, innovations, and clinical trials.
Visitors to our booth met and heard Dana-Farber experts talk about their latest research findings:
At this year's meeting, more than 19 renowned Dana-Farber and Dana-Farber/Boston Children's experts in hematological malignancies and hematology shared their discoveries, innovations, and insights from their adult and pediatric research and clinical practice.
ASH 2014 Dana-Farber Speakers
ASH 2014 Dana-Farber/Boston Children's Speakers
At Dana-Farber and Dana-Farber/Boston Children's, we're proud of our leadership role — both at each Annual Meeting and in the Society itself. Dana-Farber/Boston Children's pediatric oncologist David Williams, MD, is 2014 ASH president-elect. And Dana-Farber/BWCC medical oncologist Kenneth Anderson, MD, is 2014 ASH VP-Elect, and will become president-elect in 2015.
Dana-Farber experts presented exciting new research findings at this year's conference. Presentations included:
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: